Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03943329 · ClinicalTrials.gov registry record · NA
Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03943329 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 60 participants.
The verdict
NCT03943329, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will be a prospective, case - control trial looking at the use of a previously FDA approved device made by Stryker, a distal targeting system that eases the distal targeting of screws in cephalomedullary nails in hip and femoral shaft fractures. Patients who consent to participate in the study will either be in the control or device arm of the study depending on their surgeon.
Interventions
- PROCEDURE Standard of Care
- PROCEDURE Distal targeting device technique of distal screw placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2019-12-17 |
| Est. Completion | 2021-03-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03943329
The ClinicalTrials.gov registry entry for NCT03943329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03943329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03943329 about?
NCT03943329 is a clinical study titled "Trial of a Distal Targeting System for Cephalomedullary Nails as Part of Surgical Repair of Hip and Femoral Shaft Fractures". This study will be a prospective, case - control trial looking at the use of a previously FDA approved device made by Stryker, a distal targeting system that eases the distal targeting of screws in cephalomedullary nails in hip and femoral shaft fractures. Patients who consent to participate in the ...
What is the current status of trial NCT03943329?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2019-12-17. Estimated completion is 2021-03-07.
What interventions are being tested in trial NCT03943329?
The interventions under investigation include: Standard of Care (PROCEDURE), Distal targeting device technique of distal screw placement (PROCEDURE).
Who is sponsoring clinical trial NCT03943329?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.